###begin article-title 0
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds)
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Profiling of gene expression changes in mice harbouring the neurodegenerative Wlds mutation shows a strong correlation between changes in cell cycle pathways and altered vulnerability of terminally differentiated neurons.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 472 474 472 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 472 474 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nmnat1</italic>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 805 807 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 805 807 805 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pttg1</italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Altered neuronal vulnerability underlies many diseases of the human nervous system, resulting in degeneration and loss of neurons. The neuroprotective slow Wallerian degeneration (Wlds) mutation delays degeneration in axonal and synaptic compartments of neurons following a wide range of traumatic and disease-inducing stimuli, providing a powerful experimental tool with which to investigate modulation of neuronal vulnerability. Although the mechanisms through which Wlds confers neuroprotection remain unclear, a diverse range of downstream modifications, incorporating several genes/pathways, have been implicated. These include the following: elevated nicotinamide adenine dinucleotide (NAD) levels associated with nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1; a part of the chimeric Wlds gene); altered mRNA expression levels of genes such as pituitary tumor transforming gene 1 (Pttg1); changes in the location/activity of the ubiquitin-proteasome machinery via binding to valosin-containing protein (VCP/p97); and modified synaptic expression of proteins such as ubiquitin-activating enzyme E1 (Ube1).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 3 5 3 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 470 473 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 473 475 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Wlds expression in mouse cerebellum and HEK293 cells induced robust increases in a broad spectrum of cell cycle-related genes. Both NAD-dependent and Pttg1-dependent pathways were responsible for mediating different subsets of these alterations, also incorporating changes in VCP/p97 localization and Ube1 expression. Cell proliferation rates were not modified by Wlds, suggesting that later mitotic phases of the cell cycle remained unaltered. We also demonstrate that Wlds concurrently altered endogenous cell stress pathways.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 161 163 161 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
We report a novel cellular phenotype in cells with altered neuronal vulnerability. We show that previous reports of diverse changes occurring downstream from Wlds expression converge upon modifications in cell cycle status. These data suggest a strong correlation between modified cell cycle pathways and altered vulnerability of axonal and synaptic compartments in postmitotic, terminally differentiated neurons.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Recent studies have highlighted the important role that vulnerability of nonsomatic neuronal compartments such as axons and synapses plays in the instigation and progression of neurodegenerative diseases, including Alzheimer's disease, multiple sclerosis, prion disease, Huntington's disease, and motor neuron diseases [1-4]. However, our understanding of the independent mechanisms that are required to regulate degenerative pathways in axons and synapses remains in its infancy. One powerful experimental tool that has already yielded novel insights into such pathways is the slow Wallerian degeneration (Wlds) mutation that selectively protects axons and synapses in the central and peripheral nervous systems following a wide variety of traumatic and disease-related, degeneration-inducing stimuli [5-12].
###end p 10
###begin p 11
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 7 9 7 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 543 546 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 546 548 546 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 546 548 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 658 669 658 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 779 781 779 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 779 781 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10116">rats</span>
###xml 658 668 <span type="species:ncbi:7227">Drosophila</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
The Wlds mutation occurred spontaneously in a breeding colony of C57Bl/6 mice, resulting in a tandem triplication of an 85 kilobase region on distal chromosome 4 [13]. The Wlds gene encodes a fusion protein that comprises the full length of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1; a nicotinamide adenine dinucleotide [NAD+] synthesizing enzyme), coupled by a unique 18-amino-acid sequence to the amino-terminal 70 amino acids of the ubiquitination enzyme ubiquitination factor E4B (Ube4b) [14]. Transgenic expression of the Wlds gene is sufficient to confer the full neuroprotective phenotype in several species, including mice, rats, and Drosophila [14-16]. Despite providing substantial protection for axons and synapses, cell bodies are not protected in Wlds mice [17-19].
###end p 11
###begin p 12
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 525 527 525 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 631 639 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 799 802 799 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 802 804 802 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 802 804 802 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 932 935 932 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 935 937 935 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 935 937 935 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 948 956 948 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 960 968 960 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1338 1340 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
The Wlds protein product appears to be localized exclusively to neuronal nuclei, suggesting that it confers its neuroprotective effects indirectly via modification of endogenous cellular pathways [14,20-22], but there remains considerable controversy over which cellular pathways may need to be targeted to confer Wlds-mediated neuroprotection. For example, several studies have demonstrated that the NAD/Sirt1 pathway can modulate axonal degeneration as a result of increased NAD levels, driven by Nmnat1 in the chimeric Wlds gene [23-25]. However, NAD pathways alone are insufficient to confer the full neuroprotective phenotype in vivo [26,27]. Other studies have suggested that modifications of the ubiquitin-proteasome system are required for neuroprotection, in part because of the ability of Wlds to bind valosin-containing protein (VCP/p97) [28,29]. Genomic and proteomic studies have identified other downstream effects of Wlds expression in vivo and in vitro. For example, array experiments have revealed modified expression levels for a range of genes, including the robust downregulation of mRNA encoding pituitary tumor transforming gene 1 (Pttg1 [22,30]). Similarly, proteomic experiments have demonstrated modifications in the levels of mitochondrial and/or synaptic proteins such as ubiquitin-activating enzyme E1 (Ube1) [31]. However, a unified hypothesis that brings together these distinct observations is currently lacking.
###end p 12
###begin p 13
###xml 199 201 199 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 443 445 443 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 919 921 919 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 919 921 919 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
We made the previously unrecognized observation that many of these downstream changes also influence cell cycle. For example, Pttg1 is an oncogene with a recently established role in regulating the G1 to S phase transition of cell cycle [32]. Similarly, Ube1 is a protein with well established roles in cell cycle [33-36], and VCP/p97 localization is intricately linked to the cell cycle, with nuclear localization only occurring during late G1 phase [37]. In addition, several studies have demonstrated that NAD-dependent pathways play important roles in regulating cell cycle [38-40]. Taken together with numerous published studies reporting that cell cycle status can play an important role in modulating neuronal vulnerability and neurodegenerative pathways [41-49], these observations suggest that cell cycle modulation may provide a unified, common pathway on which genetic and proteomic changes downstream of Wlds may act to confer neuroprotection.
###end p 13
###begin p 14
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Here we show that Wlds expression in both mouse cerebellum in vivo and in HEK293 cells in vitro leads to robust increases in expression of a broad spectrum of cell cycle related genes, indicative of an attempt to re-enter cell cycle. We also provide evidence that these cell cycle changes involve all of the Wlds-mediated pathways detailed above (Pttg1, Ube1, NAD, and VCP), pushing postmitotic, terminally differentiated neurons toward cell cycle re-entry without affecting later mitotic phases. These data have identified a novel cellular phenotype in Wlds-expressing cells, unifying several diverse observations to reveal modifications in cell cycle status with concurrent alterations in cell stress. We propose that there exists a strong correlation between modified cell cycle pathways and altered vulnerability of axonal and synaptic compartments in postmitotic, terminally differentiated neurons.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Increased expression of cell cycle genes and proteins in Wlds-expressing cells in vivo and in vitro
###end title 16
###begin p 17
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 259 261 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 259 261 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 348 350 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 348 350 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 757 759 757 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 757 759 757 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 926 927 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1023 1026 1023 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1026 1028 1026 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1026 1028 1026 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1036 1037 1036 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
We used cell cycle pathway-specific RT2 profiler PCR arrays (see Materials and methods [below]) to quantify and compare the expression of cell cycle-related genes with high sensitivity. Initially, we used RNA extracted from the cerebellum of wild-type and Wlds mice because this tissue has proven ideal for comparative genomic experiments [22]. Wlds cerebellar granule cells are also known to express Wlds protein at high levels and exhibit a strong neuroprotective phenotype [22]. We compared expression levels of 84 genes that regulate the cell cycle, including transitions between each of the phases, DNA replication, checkpoints, and arrest. Seventeen out of the 84 genes examined (around 20%) had expression levels increased by more than twofold in Wlds cerebellum (Figure 1 and Table 1). The array identified changes in genes associated with many different stages of the cell cycle rather than one specific stage (Table 1). Interestingly, no cell cycle related genes appeared to be suppressed greater than twofold by Wlds (Figure 1 and Table 1).
###end p 17
###begin p 18
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 366 369 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 369 371 369 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Up-regulation of cell cycle genes in terminally differentiated neurons from Wlds mouse cerebellum in vivo. Three-dimensional bar chart taken from SuperArray analysis software (cell cycle specific SuperArray; see Materials and methods) showing fold difference in expression levels for 84 cell cycle related genes, comparing wild-type cerebellum (control sample) with Wlds cerebellum (test sample). Individual genes with greater than twofold expression change can be found in Table 1.
###end p 18
###begin p 19
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 109 111 109 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Mouse SuperArray data showing greater than twofold cell cycle RNA expression changes in the cerebellum of Wlds mice compared with wild-type controls
###end p 19
###begin p 20
SD, standard deviation.
###end p 20
###begin p 21
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 140 142 140 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 821 824 821 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 824 826 824 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 824 826 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
To confirm that RNA changes led to corresponding changes in protein levels, we quantified protein expression levels in the cerebellum of Wlds and wild-type mice in vivo. We chose to focus on one of the genes with a large RNA change and one with a smaller change, just above the twofold threshold, where good antibodies were available (cABL and Brca2, respectively; Table 1). The protein product for both of these genes exhibited corresponding increased expression levels, of a similar ratio to that seen for RNA (Figure 2). In addition, we examined protein levels of other known cell cycle regulators to show that the changes observed on the PCR arrays were not exclusive. Three of the four additional proteins examined (histone H2B, BRCA1, and phosphohistone H2Ax) exhibited significantly increased expression levels in Wlds cerebellum, which is in keeping with the general trend observed on the PCR arrays (Figure 2).
###end p 21
###begin p 22
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 232 235 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 235 237 231 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 235 237 231 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 289 291 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 499 502 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 502 504 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 502 504 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 563 566 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 566 568 562 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 566 568 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 595 597 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 598 600 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1076 1079 1072 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1079 1081 1075 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1079 1081 1075 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1089 1091 1085 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1099 1101 1095 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1121 1122 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
Quantitative fluorescent Western blots validate changes in cell cycle proteins in Wlds cerebellum in vivo. Bar chart showing percentage change in protein expression (mean +/- standard error of the mean; n >/= 3 for all proteins) in Wlds cerebellum compared with wild-type. As expected, Wlds protein expression was highly upregulated (left bar). The second portion of the graph shows increases in both pituitary tumor transforming gene 1 (Pttg1) and ubiquitin-activating enzyme E1 (Ube1) proteins in Wlds mice, both of which have previously been implicated in the Wlds neuroprotective phenotype [22,31]. The third portion of the graph shows validation for two genes highlighted on the SuperArray analysis as being upregulated by more than twofold. The final portion of the graph shows similar increases in cell cycle proteins not included on the SuperArray plate, showing that increased expression of cell cycle proteins is not restricted to those included on the SuperArray. Statistical tests were carried out comparing raw expression data from wild-type mice with those from Wlds mice. **P < 0.01, P < 0.001 by unpaired t-test (two-tailed). ns, not significant.
###end p 22
###begin p 23
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 154 156 154 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 326 328 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 437 439 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 561 564 561 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 564 565 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 585 593 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 738 740 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 738 740 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 759 760 759 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 846 847 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 950 953 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 953 954 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
Next, we established that protein levels of two other cell cycle regulators, not included on the PCR array chip but previously shown to be modified in Wlds neurons, were similarly altered. Previous studies have demonstrated that protein levels of Ube1 (a protein with known cell cycle involvement [33-36]) are increased in Wlds synapses [31], and we were able to confirm this finding by showing increased total Ube1 protein levels in Wlds cerebellum (Figure 2). In addition, immunocytochemical staining for Ube1 confirmed increased nuclear expression levels in Wlds-expressing neurons in vivo (Figure 3). We also found that Pttg1 protein levels (another protein that regulates cell cycle pathways [32]) were significantly increased in Wlds cerebellum (Figure 2), which is in keeping with changes in all other cell cycle regulators modified by Wlds. This result was surprising because although Pttg1 protein levels had not previously been examined in Wlds-expressing cells, several previous reports have identified reduced mRNA levels for Pttg1 [22,30].
###end p 23
###begin p 24
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 146 152 146 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 155 157 155 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 155 157 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 161 167 161 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d-f) </bold>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 460 462 460 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 460 462 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 546 552 546 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g-i) </bold>
###xml 789 792 789 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 792 794 792 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 792 794 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 803 805 803 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 838 839 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
Immunocytochemistry confirms increased nuclear expression of Ube1 in Wlds mouse cerebellum. Confocal micrographs of cerebellar granule cells from (a-c) Wlds and (d-f) wild-type mice. Ubiquitin-activating enzyme E1 (Ube1) is shown in green and the nuclear marker TOPRO3 is shown in blue (panels a and d show Ube1; panels b and e show TOPRO3; and panels c and f show both markers). Note how Ube1 protein appears to be more strongly expressed in the nuclei of Wlds cerebellar neurons, whereas TOPRO3 and cytoplasmic levels of Ube1 appear unchanged. (g-i) Scatter plots (line indicates mean) of fluorescence intensity (see Materials and methods) of nuclear Ube1 (panel g), nuclear TOPRO3 (panel h), and cytoplasmic Ube1 (panel i). Only nuclear Ube1 was significantly increased in intensity in Wlds neurons (P < 0.001; by unpaired, two-tailed t-test). Scale bar 20 mum.
###end p 24
###begin p 25
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 272 274 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 405 407 405 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 405 407 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 577 585 577 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 610 615 <span type="species:ncbi:9606">human</span>
###xml 902 907 <span type="species:ncbi:9606">human</span>
To verify that the alterations in cell cycle gene expression were occurring as a direct result of the presence of Wlds, and to further confirm that RNA changes observed in Wlds mouse cerebellum led to corresponding changes in protein levels, we examined the effects of Wlds on cell cycle in human embryonic kidney (HEK293) cells after transfection with enhanced green fluorescent protein (eGFP)-tagged Wlds constructs [22]. We selected HEK293 cells for our experiments for two main reasons. First, we wanted to consider whether the expression changes observed in mouse neurons in vivo could be replicated in a human cell line, as has previously been demonstrated for other Wlds-mediated changes in gene expression [22]. Second, HEK293 cells are an experimentally amenable, homogenous cell line that is routinely used to study transcriptional effects [22,50] and to model degenerative mechanisms in the human nervous system [51,52].
###end p 25
###begin p 26
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 629 630 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 845 847 845 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 845 847 845 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 890 891 890 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
As for the cerebellar experiments, we again chose initially to focus on one gene with a large RNA change (Abl1) and one with a change just above the twofold threshold (Brca2). The protein product for both of these genes exhibited corresponding increased expression levels, of a similar ratio to that seen for RNA (Figure 4). In addition, we once again examined protein levels of other known cell cycle regulators to show that the changes observed on the PCR arrays were not exclusive. All four additional proteins examined (HDAC2, histone H2B, acetyl histone H3, and phosphohistone H2Ax) showed increased expression levels in Wlds-transfected cells, which is in keeping with the general trend observed on the PCR arrays (Figure 1). These experiments also provided further confirmation that both Ube1 and Pttg1 protein levels are increased by Wlds expression (Figure 4; compare with Figures 2 and 3).
###end p 26
###begin p 27
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 246 249 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 249 250 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 249 250 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 375 377 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 592 595 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 595 597 591 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 595 597 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 659 662 655 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 662 664 658 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 662 664 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 691 693 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 694 696 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1134 1137 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1137 1138 1133 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1137 1138 1133 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 1188 1190 1184 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1201 1203 1197 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1223 1224 1219 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Quantitative fluorescent Western blots validate changes in cell cycle proteins in Wlds-expressing HEK293 cells in vitro. Bar chart showing percentage change in protein expression (mean +/- standard error of the mean; n >/= 3 for all proteins) in Wlds-transfected HEK293 cells compared with enhanced green fluorescent protein (eGFP)-transfected control cells. As expected, Wlds protein expression was highly upregulated (left bar). The second portion of the graph shows increases in both pituitary tumor transforming gene 1 (Pttg1) and ubiquitin-activating enzyme E1 (Ube1) proteins following Wlds transfection, both of which were previously implicated in the Wlds neuroprotective phenotype [22,31]. The third portion of the graph shows validation for two genes highlighted on the SuperArray analysis as being upregulated by more than twofold. The final portion of the graph shows similar increases in cell cycle proteins not included on the SuperArray plate, showing that increased expression of cell cycle proteins is not restricted to those included on the SuperArray. All genes were significantly increased in expression levels in Wlds-transfected cells compared with control cells. **P < 0.01, ***P < 0.001 by unpaired t-test (two-tailed).
###end p 27
###begin p 28
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 583 591 583 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 628 631 628 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 631 633 631 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 631 633 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b,e</xref>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 805 807 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 805 807 805 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 983 986 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 986 988 986 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 986 988 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a-f</xref>
###xml 1046 1049 1046 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1049 1051 1049 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1049 1051 1049 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1310 1314 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5g-i</xref>
Because the Wlds protein is known to have a predominantly nuclear distribution [20,21], and most cell cycle proteins modulate cell cycle via interactions in the nucleus, we next tested whether Wlds expression altered the nuclear expression of cell cycle proteins. We chose to investigate the nuclear distribution of phosphohistone H2Ax in Wlds-transfected HEK293 cells because this protein has a well-established role in the cell cycle [53,54] and was among the largest protein changes identified in HEK293 cells (Figure 5; see Figures 2 and 4 for phosphohistone H2Ax protein levels in vivo and in vitro). Not all cells express Wlds using our transfection protocol, as identified by the presence of an eGFP signal (Figure 5b,e). We were therefore able to compare directly experimental cells expressing Wlds or eGFP-only controls with neighbouring nontransfected cells. Anti-phosphohistone H2Ax antibodies revealed intense nuclear spots of phosphohistone H2Ax in all cells expressing Wlds (Figure 5a-f). However, neighbouring cells not expressing Wlds did not show any phosphohistone H2Ax nuclear puncta. No phosphohistone H2Ax staining was observed in control cells transfected with eGFP, indicating that the response was not simply the result of a large accumulation of foreign protein in the nucleus (Figure 5g-i).
###end p 28
###begin p 29
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 178 184 178 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-f) </bold>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 229 231 229 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 244 250 244 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g-i) </bold>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 646 648 646 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 646 648 646 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 736 738 736 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 736 738 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 868 871 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 871 872 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 933 936 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 936 938 936 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 936 938 936 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 958 961 958 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 961 963 961 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 961 963 961 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1005 1008 1005 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1008 1010 1008 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1008 1010 1008 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
Increased expression of the cell cycle marker phosphohistone H2Ax in Wlds transfected HEK293 cells. Confocal micrographs of HEK293 cells 5 days after transfection with either an (a-f) enhanced green fluorescent protein (eGFP)-Wlds construct or (g-i) a eGFP-only control construct. Immunocytochemical labeling of phosphohistone H2Ax is shown in red, the nuclear marker TOPRO3 is shown in blue, and constructs are expressing in green (panels a, d and g show H2Ax and TOPRO3; panels b, e and h show construct and TOPRO3; and panels c, f and i show all three markers). Note how phosphohistone H2Ax protein can only be seen in nuclear puncta where Wlds is being expressed. Note that not all cells have transfected with construct, and non-Wlds expressing cells identifiable by their TOPRO3 labeled nuclei do not have corresponding H2Ax puncta. H2Ax puncta were found in all Wlds-expressing cells, regardless of the nuclear distribution of Wlds (panels a to c show Wlds in nuclear inclusions; panels d to f show Wlds expressed in a strong diffuse manner throughout the nucleus). Scale bar 10 mum.
###end p 29
###begin p 30
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a-b</xref>
###xml 776 778 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c</xref>
###xml 1102 1105 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1105 1107 1103 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1105 1107 1103 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 239 244 <span type="species:ncbi:9606">human</span>
Because we had found that a broad spectrum of cell cycle genes and proteins were modified by Wlds (Table 1), we next tested whether Wlds can influence neurons to pass through the complete cell cycle by quantifying proliferation rates in a human neuronal cell line (NT2 cells) using an MTT (3-[4,5-dimethylthiazolyl-2]-2,5-diphenyltetrazolium bromide) assay. Introduction of a Wlds construct into NT2 cells did not modify cell proliferation rates compared with vector-only transfected cells, either at 48 or 72 hours after transfection, or at low, medium, or high doses (Figure 6a-b). These findings were confirmed using tritiated thymidine uptake assays where values were normalized to low dose treatment (mean count: 14,770 +/- 1,259 disintegrations per minute [DPM]; Figure 6c). Tritiated thymidine uptake assays were performed at 48 hours post-transfection in order to corroborate data from MTT assays generated at the same experimental time point and because this was the time point anticipated to give the maximum chance of detecting a proliferative change in these cells. These data suggest that Wlds upregulates the expression of a broad range of cell cycle regulators, pushing cells toward cell cycle re-entry, but that pathways influencing later stages of the cycle, such as mitotic cell division, remain inhibited.
###end p 30
###begin p 31
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 3 5 3 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 217 219 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 280 284 280 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 442 446 442 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 552 556 552 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 697 699 697 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 741 750 741 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">post hoc </italic>
Wlds does not influence late stages of cell cycle regulating cell proliferation in NT2 cells. Bar charts showing relative proliferation rates of NT2 cells transfected with either a control vector (black bars) or a Wlds vector (white bars) at low, medium, and high concentrations. (a) Panel a shows no difference in proliferation at 48 hours after transfection using an MTT (3-[4,5-dimethylthiazolyl-2]-2,5-diphenyltetrazolium bromide) assay. (b) Panel b similarly shows no difference in proliferation at 72 hours after transfection using an MTT assay. (c) Panel c shows no difference in proliferation at 48 hours after transfection using a tritiated thymidine incorporation assay (all comparisons P > 0.05; analysis fo variance with Tukey's post hoc test).
###end p 31
###begin p 32
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 481 483 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 573 576 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 576 577 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 576 577 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 611 612 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 731 734 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 734 735 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 734 735 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 850 853 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 853 855 852 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 853 855 852 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
In order to confirm that Wlds-mediated changes in cell cycle genes/proteins were pushing terminally differentiated neurons toward cell cycle re-entry rather than inhibiting cell cycle activation, we compared the profile of Wlds-mediated protein changes with changes induced by a well known pharmacologic inhibitor of the cell cycle: the cyclin-dependent kinase inhibitor flavopiridol. Treatment of HEK293 cells with flavopiridol at an established active concentration (10 mumol/l [48]) resulted in suppression of six out of eight cell cycle proteins that were increased in Wlds-transfected HEK293 cells (Figure 7). Thus, pharmacologic inhibition of the cell cycle also induced changes in cell cycle proteins known to be altered by Wlds, but importantly these changes in expression levels occurred in the opposite direction. These data confirmed that Wlds reactivates dormant cell cycle pathways, pushing cells toward cell cycle re-entry rather than inhibiting it.
###end p 32
###begin p 33
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 78 79 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 122 126 122 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 249 251 249 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 347 350 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 350 352 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 350 352 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 487 491 486 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 628 631 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 631 633 630 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 631 633 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 772 775 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 775 777 774 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 775 777 774 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
Pharmacological inhibition of cell cycle progression (flavopiridol) versus Wlds: opposing changes in cell cycle proteins. (a) Bar chart showing protein expression assayed by quantitative fluorescent western blots in HEK293 cells transfected with Wlds (black bars) or treated with exogenous flavopiridol (10 mumol/l; cell cycle inhibitor). Whereas Wlds induced increases in all cell cycle proteins, flavopiridol treatment led to decreased expression of the majority of proteins examined. (b) Representative Western blots showing pituitary tumor transforming gene 1 (Pttg1) protein levels in HEK293 cells comparing control versus Wlds transfected cells (top panel) and control versus flavopiridol treated cells (bottom panel). Note how Pttg1 protein levels are increased by Wlds expression and decreased by flavopiridol treatment.
###end p 33
###begin title 34
Role of Pttg1, NAD, and VCP pathways in mediating cell cycle modulation
###end title 34
###begin p 35
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 32 34 32 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 225 227 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 340 342 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 416 417 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 665 667 665 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 665 667 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 1044 1047 1044 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1047 1048 1047 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 1121 1124 1121 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1124 1126 1124 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1124 1126 1124 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1136 1138 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
After demonstrating that the Wlds gene robustly modifies cell cycle status in a variety of cell types in vivo and in vitro, we next investigated whether any of the previously identified downstream modifications induced by Wlds play a role in mediating cell cycle changes. First we investigated whether Pttg1 alone, as a known regulator of G1 to S phase cell cycle transition [32] with increased protein levels in Wlds-expressing cells (see Figures 2 and 4), was capable of mediating Wlds-induced effects on cell cycle proteins. We compared expression levels of four previously highlighted cell cycle proteins following transfection of HEK293 cells with either a Wlds construct [22] or a Pttg1 over-expression construct [55] (Figure 8a). Three of the four proteins examined were not modified by Pttg1 expression alone (Figure 8a), suggesting that other pathways are also required to induce the full range of cell cycle related changes (see below). However, Ube1 upregulation was induced by Pttg1 over-expression to a similar extent as seen with Wlds. This suggests that elevated Ube1 protein levels previously reported in Wlds synapses [31] are occurring downstream from increases in Pttg1 protein levels.
###end p 35
###begin p 36
###xml 198 202 198 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 303 305 303 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 638 641 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 641 643 641 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 690 694 690 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
Over-expression of ubiquitinatable Pttg1 is required to elicit changes in the cell cycle protein Ube1. Presented are quantitative fluorescent Western blots of HEK293 cells (n = 3 for all proteins). (a) Changes in four cell cycle proteins known to be modified by Wlds after transfection with either a Wlds construct (black bars) or a pituitary tumor transforming gene 1 (Pttg1) over-expression construct (white bars). The first portion of the graph shows normalized Pttg1 levels accounting for differences in transfection efficiency. Note how Pttg1 induced the same level of increase in ubiquitin-activating enzyme E1 (Ube1) expression as Wlds but had no effect on the three other proteins. (b) changes in Ube1 can only be induced by a ubiquitinatable form of Pttg1, because transfection with a non-ubiquitinatable form of Pttg1 (gray bars) could not elicit any changes in Ube1 expression (right portion of graph).
###end p 36
###begin p 37
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
Pttg1 is currently the only known physiological substrate for the E4 ubiquitination factor Ube4b [56], which is one of the constituent parts of the chimeric Wlds gene [13]. In order to establish whether the ability of Pttg1 to be ubiquitinated is important for the regulation of Ube1, we repeated the experiment using an over-expression construct containing a non-ubiquitinatable form of Pttg1 [57]. The inability to be ubiquitinated completely abolished the ability of Pttg1 to increase Ube1 protein levels (Figure 8b), showing that ubiquitination of Pttg1 by Ube4b (and/or other proteins in the ubiquitin pathway) is likely to be important for Wlds-mediated cell cycle changes.
###end p 37
###begin p 38
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 402 403 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 465 467 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 719 728 719 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 757 760 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 760 761 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 760 761 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 959 962 959 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 962 964 962 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 962 964 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1120 1121 1120 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 1132 1133 1132 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1231 1232 1231 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 1279 1282 1279 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1282 1284 1282 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1282 1284 1282 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1411 1414 1411 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10a</xref>
###xml 1801 1804 1801 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10b</xref>
###xml 1902 1905 1902 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1905 1906 1905 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1905 1906 1905 1906 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 494 499 <span type="species:ncbi:9606">human</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
###xml 964 969 <span type="species:ncbi:10090">mouse</span>
Next, we investigated whether NAD-dependent pathways play a role in mediating cell cycle changes, because several recent studies have suggested that the Nmnat1 portion of the chimeric Wlds gene plays a significant role in conferring a neuroprotective phenotype by elevating NAD levels and increasing sirtuin activity [23-25]. To examine whether NAD pathways influence cell cycle changes observed in Wlds-expressing cells, we performed cell cycle pathway specific RT2 profiler PCR arrays (using human rather than mouse arrays; see Materials and methods [below]) on HEK293 cells treated with 1 mmol/l NAD applied exogenously to the culture medium. This NAD treatment has previously been shown to confer axonal protection in vitro [23] and to mediate selected Wlds-induced transcriptional changes [22]. Forty-eight out of the 84 genes examined exhibited greater than twofold changes in expression after NAD treatment. In a similar result to that obtained in the Wlds mouse cerebellar array experiments, the vast majority (47 out of the 84) of modified genes had increased expression levels in the NAD treated cells (Figure 9 and Table 2). Only one cell cycle related gene appeared to be suppressed greater than twofold by NAD (Figure 9). A direct comparison of SuperArray data from Wlds cerebellum and NAD-treated HEK293 cells showed changes of a similar magnitude for eight out of the nine genes examined (Figure 10a; only nine candidate genes could be directly compared due to their presence/alteration on both arrays). Increases in protein expression levels of Pttg1, BRCA2, BRCA1, and H2Ax in NSC34 cells treated with 1 mmol/l NAD for 4 days confirmed that these NAD-induced changes extend beyond those included on the SuperArray, extend to the protein level, and can occur in neuronal cells (Figure 10b). These data suggest that elevated exogenous NAD levels can mimic many, but importantly not all, Wlds-induced cell cycle changes.
###end p 38
###begin p 39
Upregulation of cell cycle genes in HEK293 cells treated with 1 mmol/l exogenous NAD. Three-dimensional bar chart taken from SuperArray analysis software (cell cycle SuperArray; see Materials and methods) showing fold difference in expression levels for 84 cell cycle related genes comparing vehicle treated HEK293 cells (control sample) with nicotinamide adenine dinucleotide (NAD) treated HEK293 cells (test sample). Individual genes with a greater than twofold expression change can be found in Table 2. NAD, nicotinamide adenine dinucleotide.
###end p 39
###begin p 40
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 68 72 68 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 397 401 397 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
NAD-induced changes in cell cycle genes mimic Wlds-induced changes. (a) Bar chart showing greater than twofold changes in cell cycle genes from SuperArray experiments on Wlds cerebellum (black bars; see Table 1) compared with nicotinamide adenine dinucleotide (NAD) treated HEK293 cells (white bars; see Table 2). Of the nine genes examined, eight responded similarly in both experimental groups. (b) Bar chart showing percentage difference in protein expression in NSC34 cells treated with 1 mmol/l exogenous NAD as compared with control-treated cells.
###end p 40
###begin p 41
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SuperArray data showing greater than twofold cell cycle RNA expression changes in NAD-treated HEK293 cells compared with controls
###end p 41
###begin p 42
NAD, nicotinamide adenine dinucleotide; SD, standard deviation.
###end p 42
###begin p 43
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 531 533 531 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 863 864 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 863 864 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 919 921 919 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 919 921 919 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1112 1115 1112 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1115 1117 1115 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1115 1117 1115 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1180 1183 1180 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1183 1185 1183 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1183 1185 1183 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1279 1281 1279 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1343 1346 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1346 1347 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1346 1347 1346 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
Alongside identified changes in Pttg1/Ube1 expression and NAD pathways, previous studies have implicated VCP-mediated pathways (also known as p97 and CDC48) in Wlds-mediated neuroprotection, via its interaction with the Ube4b component of the Wlds chimeric protein [28]. Moreover, VCP is known to be important in early stages of cell cycle progression; VCP is normally localised in the endoplasmic reticulum during nonproliferative states (for example, terminally differentiated neurons), but relocates to the nucleus during late G1 phase in a cell cycle dependent manner [37]. Thus, VCP localisation would not normally be observed in the nucleus of terminally differentiated neurons unless cell cycle had been reactivated and they are progressing toward S phase. To examine whether VCP redistribution associated with modified cell cycle status is modified by Wlds, we examined VCP localization in the cerebellum of Wlds and wild-type mice. These experiments revealed an expected cytoplasmic, non-nuclear localization in wild-type neurons, but distinct, strong nuclear puncta in most cerebellar granule cells in Wlds mice (Figure 11). As predicted from the finding that VCP binds Wlds [28], VCP localization in the nucleus was consistently found in the same nuclear puncta as Wlds protein (Figure 11). These data provide further evidence that Wlds-expressing cells are being pushed toward the early phases of cell cycle re-entry and suggest that VCP binding may play a role in this process.
###end p 43
###begin p 44
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 164 170 164 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 179 185 179 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d-f) </bold>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 519 521 519 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 640 642 640 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
Increased nuclear expression of cell cycle marker VCP corresponding with Wlds expression in mouse cerebellum. Confocal micrographs of cerebellar granule cells from (a-c) Wlds and (d-f) wild-type mice. Valosin-containing protein (VCP) is shown in green, the nuclear marker TOPRO3 is shown in blue, and Wlds protein in red (panels a and d show VCP and TOPRO3; panels b and e show Wlds and TOPRO3; and panels c and f show all three markers). Note how VCP protein can be seen in nuclear puncta with high frequency where Wlds is being expressed (arrows in panels a and c show four out of nine examples in this field of view). The majority of Wlds puncta coincided with VCP puncta. Nuclear puncta of VCP were rarely observed in wild-type cerebellar granule cells. As expected, VCP was detectable as diffuse staining in the cytoplasm of neurons in both strains of mice. Scale bar = 20 mum.
###end p 44
###begin p 45
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 287 289 287 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
Thus, Pttg1/Ube1, NAD, and VCP pathways are all likely to be involved in mediating Wlds-induced modifications in cell cycle status. Taken together, these findings suggest that previous observations of apparently unrelated changes in gene and protein expression/activity downstream of Wlds can in fact be unified by their ability to modify the cell cycle.
###end p 45
###begin title 46
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Modifications in cell stress pathways induced by Wlds in vivo and in vitro
###end title 46
###begin p 47
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 389 391 389 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12</xref>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 502 503 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 575 577 575 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 575 577 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 665 667 665 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 665 667 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
Changes in cell cycle status in terminally differentiated neurons are often associated with corresponding changes in cell stress pathways [58-60]. To examine whether cell stress pathways were also altered in Wlds-expressing cells, we used cell stress pathway-specific RT2 profiler PCR arrays (see Materials and methods [below]) to compare mRNA levels in the cerebellum of wild-type and Wlds mice (Figure 12). Fourteen out of the 84 genes contained on the array were modified greater than twofold by Wlds, showing that a subset of cell stress pathways are also modified in Wlds (Figure 12 and Table 3). In contrast to the results from cell cycle arrays, however, Wlds neurons revealed both increases and decreases across a range of different cell stress proteins.
###end p 47
###begin p 48
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 352 354 352 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Widespread alterations in cell stress genes in uninjured/untreated Wlds mouse cerebellum in vivo. Three-dimensional bar chart taken from SuperArray analysis software (cell stress SuperArray; see Materials and methods) showing fold difference in expression levels for 84 cell stress related genes comparing wild-type cerebellum (control sample) with Wlds cerebellum (test sample). Individual genes with a greater than twofold expression change can be found in Table 3.
###end p 48
###begin p 49
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 110 112 110 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Mouse SuperArray data showing greater than twofold cell stress RNA expression changes in the cerebellum of Wlds mice compared with wild-type controls
###end p 49
###begin p 50
eGFP, enhanced green fluorescent protein; SD, standard deviation.
###end p 50
###begin p 51
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 37 39 37 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F13">13</xref>
###xml 355 364 355 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 549 552 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 552 554 552 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 552 554 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 563 571 563 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 657 659 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 657 659 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 667 672 667 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F13">13a-f</xref>
###xml 718 721 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 721 723 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 721 723 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1018 1023 1018 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F13">13g-i</xref>
###xml 1131 1134 1131 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1134 1136 1134 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1134 1136 1134 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1147 1154 1147 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1365 1368 1361 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1368 1370 1364 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1368 1370 1364 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1375 1383 1371 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1384 1386 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1449 1452 1445 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1452 1454 1448 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1452 1454 1448 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1590 1593 1586 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1593 1594 1589 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1593 1594 1589 1590 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
Finally, in order to confirm that Wlds altered nuclear localization, as well as expression, of cell stress proteins (as for cell cycle proteins shown in Figures 3 and 5), we investigated the expression and distribution of stress-induced phosphoprotein 1 (STI1) in Wlds-transfected HEK293 cells (Figure 13). We chose to use STI1 as a marker of cell stress in vitro in order to expand our coverage of cell stress modifications beyond those genes/proteins incorporated on the array chip and also because STI1 protein levels are known to be modified in Wlds synapses in vivo [31]. Anti-STI1 antibodies revealed nuclear spots of STI1 in most cells expressing Wlds (Figure 13a-f). However, neighbouring cells not expressing Wlds (because of less than 100% transfection efficiency) did not show any STI1 nuclear puncta. No STI1 staining was seen in control cells transfected with eGFP, indicating that stress responses were not simply occurring due to the presence of a large amount of foreign protein in the nucleus (Figure 13g-i). These findings were supported by data from quantitative Western blotting of STI1 protein levels in whole Wlds cerebellum in vivo, where STI1 levels were increased by 71.6 +/- 6.8% (mean +/- standard error of the mean; data not shown). Interestingly, we previously showed that STI1 protein levels are decreased in synapses protected by the Wlds gene in vivo [31]. The finding that nuclear STI1 immunoreactivity increases in Wlds transfected HEK293 cells suggests that some stress proteins may exhibit differential compartmental expression via redistribution within Wlds-expressing neurons, rather than simply having altered expression levels.
###end p 51
###begin p 52
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 172 178 172 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-f) </bold>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 223 225 223 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 241 247 241 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g-i) </bold>
###xml 384 386 384 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 610 612 610 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 610 612 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
Increased nuclear expression of cell stress marker STI1 corresponding with Wlds expression in HEK293 cells. Confocal micrographs of HEK293 cells transfected with either an (a-f) enhanced green fluorescent protein (eGFP)-Wlds construct or an (g-i) eGFP alone control construct. Stress induced phosphoprotein 1 (STI1) is shown in red, the nuclear marker TOPRO3 is shown in blue, and Wlds protein in green (panels a, d and g show STI1 and TOPRO3; panels b, e and h show construct and TOPRO3; and c, f and i show all three markers). Note how STI1 protein can be seen in nuclear puncta with high frequency where Wlds is being expressed, but was never observed in non-Wlds-expressing cells. The majority of Wlds puncta coincided with STI1 puncta. Nuclear puncta of STI1 were never observed in eGFP transfected control cells (panels g-i). Scale bar = 10 mum.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 246 248 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 540 548 540 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 794 797 794 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 797 799 797 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 797 799 797 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 910 913 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 913 915 913 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 913 915 913 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1049 1052 1049 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1052 1054 1052 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1052 1054 1052 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
Here, we show that a strong correlation exists between modified cell cycle pathways and altered vulnerability of axonal and synaptic compartments in postmitotic, terminally differentiated neurons. We have demonstrated that the neuroprotective Wlds chimeric gene leads to a robust increase in expression of a broad spectrum of cell cycle-related genes in terminally differentiated neurons. These changes are indicative of an attempt to re-enter cell cycle in postmitotic neurons. Cell cycle alterations were identified in cerebellar neurons in vivo and could be replicated in HEK293 cell lines in vitro. We demonstrate that NAD, Pttg1/Ube1, and VCP pathways are all likely to be responsible for mediating distinct subsets of these downstream changes. Data from proliferation assays showing that Wlds does not alter cell division or proliferation rates suggests that terminally differentiated neurons expressing Wlds are pushed toward cell cycle re-entry, but do not go on to enter proliferation and growth phases. We also show that expression of the Wlds gene leads to modifications in endogenous cell stress pathways that are likely to result from modifications in cell cycle status.
###end p 54
###begin p 55
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 378 380 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 590 592 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 590 592 590 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
Contrary to previous suggestions that Wlds-expressing neurons are 'normal', with the exception of a phenotype solely affecting axonal degeneration pathways [1], our experiments have revealed a novel cellular phenotype in Wlds-expressing cells: modifications in cell cycle status. This finding brings together diverse observations from several disparate studies investigating Wlds mechanisms (changes in Pttg1/Ube1, NAD, and VCP/p97 pathways), suggesting that modified cell cycle status might be a common endogenous pathway through which genomic and proteomic modifications downstream of Wlds can influence neuronal vulnerability.
###end p 55
###begin title 56
Pttg1/Ube1 pathways
###end title 56
###begin p 57
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 314 316 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 762 765 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 765 767 765 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 765 767 765 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 918 921 918 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 921 922 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 921 922 921 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1465 1468 1465 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1468 1469 1468 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 1468 1469 1468 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
Several studies have shown, using a range of experimental approaches and platforms, that Wlds robustly downregulates expression of Pttg1 mRNA [22,30]. Pttg1 plays a well established role in sister chromatid separation during mitosis, but recent data have identified an important additional role as a regulator of G1 to S phase cell cycle transition [32]. In the present study we showed that Pttg1 protein levels are significantly increased in Wlds-expressing cells. The most parsimonious explanation for the differences between protein and mRNA levels is that decreases in mRNA are generated by a compensatory, self-regulating feedback loop responding to elevated levels of Pttg1 protein. Because Pttg1 is the only known substrate for the Ube4b component of the Wlds gene [56], it is tempting to speculate that elevated Pttg1 protein levels result from abnormal ubiquitination and targeting for degradation, caused by Wlds-mediated alterations in the ubiquitin-proteasome pathway [28,29]. This finding also has implications for previous attempts to directly link Pttg1 to neuroprotection, because earlier studies examined neurodegenerative responses in Pttg1 null mice [22]. The current data suggest that repeating these experiments in Pttg1 over-expressing mice might reveal a neuroprotective phenotype, although the undoubted contribution made by other pathways (see below) suggests that Pttg1 over-expression alone would be unlikely to confer the full levels of Wlds-mediated neuroprotection.
###end p 57
###begin p 58
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 69 71 69 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 386 388 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 386 388 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 789 792 789 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 792 794 792 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 792 794 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 919 921 919 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
We have also shown that increased Pttg1 protein levels induced by Wlds are responsible for mediating corresponding increases in expression of another cell cycle-related protein, namely Ube1. Thus, Pttg1 is likely to be a partial mediator of other cell cycle changes induced by Wlds. We previously identified increased protein levels of Ube1 in a population of striatal synapses from Wlds mice known to be protected from degeneration [31], suggesting that Ube1 may also play a role in directly modulating degenerative pathways in synaptic compartments of neurons. Importantly, we also found that the ability of Pttg1 to increase Ube1 protein levels was abolished if Pttg1 was expressed in a non-ubiquitinatable form. Because Pttg1 is the only known substrate for the Ube4b component of the Wlds gene [56], these data suggest that modified ubiquitination of Pttg1 by Ube4b (either in its native form or as part of the Wlds protein) is likely to be required to mediate downstream changes in proteins such as Ube1. However, at this stage we cannot rule out the possibility that other proteins in the ubiquitin pathway alongside Ube4b are also responsible for mediating this response.
###end p 58
###begin title 59
NAD pathways
###end title 59
###begin p 60
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 111 113 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 416 417 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 913 916 913 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 916 917 916 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 1058 1066 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1069 1078 1069 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The most convincing evidence to date for the involvement of a single pathway in downstream mediation of the Wlds phenotype has come from studies showing that the Nmnat1 portion of the chimeric Wlds gene confers a neuroprotective phenotype via modulation of NAD levels [23-25]. Here, we have shown that experimental manipulation of NAD levels mimics many (but by no means all) of the cell cycle changes induced by Wlds. This finding raises the possibility that at least part of the NAD-mediated neuroprotective phenotype is generated by modulating cell cycle status. This suggestion is supported by several studies demonstrating that sirtuin-dependent pathways (which mediate the NAD neuroprotective phenotype [23]) play important roles in regulating cell cycle [38-40]. However, as with the Pttg1 findings discussed above, it is unlikely that NAD-mediated changes alone are sufficient to induce the full range of Wlds-mediated cell cycle changes, because NAD over-expression alone is not thought to be sufficient to confer the full neuroprotective phenotype in vivo or in vitro [26,27].
###end p 60
###begin title 61
VCP/p97 pathways
###end title 61
###begin p 62
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 243 245 243 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 365 367 365 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 365 367 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 553 556 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 556 558 556 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 556 558 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 701 704 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 704 706 704 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
Alongside Pttg1 and NAD, pathways mediated by VCP (also known as p97 and CDC48) have also been shown to influence cell cycle [61]. For example, although VCP is predominantly a cytoplasmic protein, it is known to enter the nucleus during late G1 phase [37]. Here, we have shown that VCP, which is currently the only known binding partner for the Ube4b portion of Wlds [28,62], is localized to the nucleus in the majority of Wlds-expressing neurons. This is further corroborating evidence that cell cycle has been reactivated in terminally differentiated Wlds neurons and that they are progressing toward (or beyond) S phase. Although binding to VCP has not yet been demonstrated to be required for the Wlds phenotype, the present study suggests that if this is an important event, VCP may be acting via regulation of the cell cycle in a similar manner to Pttg1. Cell cycle events potentially attributable to VCP pathways detected in the current experiments include changes in expression levels of BRCA proteins that are known to interact with VCP in the nucleus [63].
###end p 62
###begin title 63
Cell cycle pathways and neurodegeneration
###end title 63
###begin p 64
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 23 25 23 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1377 1380 1377 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 1380 1382 1380 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 1380 1382 1380 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
The hypothesis that Wlds may be modifying neurodegenerative pathways in axons and synapses via modulation of the cell cycle is in keeping with other literature on somatic neurodegeneration, in which cell cycle is known to influence vulnerability significantly. For example, it is now known that postmitotic, terminally differentiated neurons in the adult nervous system are not 'permanently postmitotic', but rather depend upon the constant suppression of cell cycle pathways to maintain their arrested status [41]. The ability to control cell cycle pathways is therefore a critical factor in stopping neurons entering a vulnerable state, where the risk for neurodegenerative mechanisms being instigated increases significantly [41-44]. Numerous examples of cell cycle regulation gone awry, modifying neuronal vulnerability, can be found in neurodegenerative conditions such as motor neuron disease, Alzheimer's disease, and stroke [45,46]. Furthermore, pharmacologic manipulation of cell cycle progression has been used to confer somatic neuroprotection in animal models of traumatic brain injury and stroke [47,48]. The current data suggest that the influence of cell cycle status on neuronal vulnerability is likely to extend beyond neurodegenerative mechanisms resident in cell soma to incorporate independent degenerative pathways in axonal and synaptic compartments. The Wlds gene may therefore provide an important experimental tool for future investigations into pathways through which cell cycle status modulates neuronal vulnerability.
###end p 64
###begin p 65
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 245 247 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 577 586 577 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The current data are also likely to be important for interpreting previous and future studies concerning Wlds-mediated neuroprotection both in vivo and in vitro. Because endogenous cell cycle and cell stress pathways are robustly modified by Wlds expression, it is difficult to imagine that Wlds-expressing cells do not have any other covert cellular phenotypes alongside neuroprotection. These may introduce additional variables that could conceivably alter experimental outcomes (for example, comparing Nmnat over-expressing cells in vivo with cells exposed to exogenous NAD in vitro [23-27]).
###end p 65
###begin p 66
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 524 526 524 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
Current opinion suggests that cell cycle re-entry is damaging to neurons, whereas blocking cell cycle decreases vulnerability [41-44]. The finding that the neuroprotective Wlds gene pushes neurons toward cell cycle re-entry therefore appears at odds with this hypothesis. There are two possible explanations for this discrepancy. First, it is possible that the basic principle of re-entry is bad/suppression is good may not hold for all neurodegenerative pathways. Second, and perhaps more plausibly, it is possible that Wlds acts to 'prime' the cell against future neurodegenerative insults by inducing early-stage cell cycle changes - and cell stress modifications - without going as far as affecting proliferation and growth stages. This potential mechanism of action is in keeping with a known role for preconditioning, sublethal 'priming' events in conferring neuroprotection by modifying endogenous stress pathways [64-67].
###end p 66
###begin title 67
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
Cell stress pathways and Wlds
###end title 67
###begin p 68
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 62 64 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 268 270 268 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 576 578 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 576 578 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Our finding that cell stress pathways are also modified in Wlds mice, suggesting a possible 'primed state' of Wlds neurons, is in keeping with the findings of other recent studies. For example, it was recently demonstrated that the NMNAT1 component of the chimeric Wlds gene has functions alongside those involving NAD, acting as a chaperone for stress-response proteins such as heat shock protein-70 [68] (Wishart TM, Gillingwater TH, unpublished observations). In addition, we have recently shown that the mitochondrial proteome is modified at a basal level in protected Wlds synapses [31], suggesting intrinsic differences in the ability to respond to cell stress stimuli. This hypothesis has received experimental support from another recent study showing that NMNAT1 can protect against mitochondrial and oxidative stress [69].
###end p 68
###begin p 69
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 620 623 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
Our study has identified possible individual stress-related proteins that may play an important role in the cell stress response in Wlds neurons. Interestingly, several of these proteins have already been implicated in other neuroprotective situations. For example, STI1 - shown in previous work [31] and the present study to have altered levels and subcellular localization in Wlds-expressing cells - appears to play an important role in neuroprotection and neuritogenesis [70] as well as in cell proliferation [71,72]. Further investigations into the in vivo role played by individual cell stress proteins modified by Wlds, such as STI1, in modulating neuronal phenotypes may therefore provide important insights into mechanisms underlying axonal and synaptic vulnerability.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 226 228 226 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 226 228 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 288 296 288 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 772 774 772 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 772 774 772 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
We have identified a strong and robust correlation between modified cell cycle pathways and altered vulnerability of axonal and synaptic compartments in terminally differentiated neurons by showing that the neuroprotective Wlds gene modifies cell cycle and cell stress status in vivo and in vitro. We conclude that Wlds-expressing cells have a potentially important, previously unreported cellular phenotype that is characterized by reactivation of normally suppressed cell cycle pathways in terminally differentiated neurons. We propose that multiple NAD-, Pttg1/Ube1-, and VCP-dependent pathways are likely to be required to modulate these cell cycle changes. The data suggest that further investigations into the role of cell cycle and cell stress status induced by Wlds are likely to provide insights into mechanisms that regulate axonal and synaptic degeneration in neurodegenerative disease.
###end p 71
###begin title 72
Materials and methods
###end title 72
###begin title 73
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse tissue and cell lines/treatments
###end title 73
###begin p 74
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S </sup>
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>S</italic></sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">Mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
Natural mutant C57Bl6/WldS (WldS) mice and C57Bl/6 (wild type) mice (all aged 6 to 8 weeks) were obtained from Harlan Olac Laboratories (Bicester, UK) and housed within the animal care facilities in Edinburgh. Mice (minimum three mice per experimental group) were killed by cervical dislocation and the cerebellum was rapidly removed.
###end p 74
###begin p 75
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 274 277 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 277 279 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 277 279 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 280 282 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 292 294 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 328 330 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 382 383 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 527 529 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 135 141 <span type="species:ncbi:9913">bovine</span>
HEK293 and NSC34 (a mouse motor neuron-like cell line [73]) cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) at 37degreesC in 5% carbon dioxide. For transfection with eGFP-Wlds [22], Pttg1 [55], and non-ubiquitinatable Pttg1 [57], 5 mg of the DNA was mixed with 10% (vol/vol) CaCl2. An equal volume of N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid was added and the solution gently dropped onto the HEK293 cell culture [22]. For some experiments, 1 mmol/l NAD (Sigma-Aldrich, Gillingham, UK) or 10 mumol/l Flavopiridol (obtained through the National Cancer Institute, Rockville, MD, USA) was added to the medium. All cells were incubated for 4 to 5 days and were checked on a phase contrast microscope before proceeding to either immunocytochemistry/microscopy or extraction of protein and/or RNA (at least three cultures for all transfections and treatments).
###end p 75
###begin title 76
RNA and protein extraction
###end title 76
###begin p 77
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
RNA was extracted from cerebella of age-matched and sex-matched mice, or HEK293 cells, in tri-reagent (Sigma) in accordance with the manufacturer's instructions, as previously described [22]. Protein was extracted from cerebella of age-matched and sex-matched mice, or HEK293 cells, in RIPA buffer with 10% protease inhibitor cocktail (Sigma) [31].
###end p 77
###begin title 78
Super arrays
###end title 78
###begin p 79
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Mouse cell cycle (PAMM-020A), cell stress (PAM-003A), and human cell cycle (PAHS-020A) focused pathway arrays (Tebubio Superarrays, Peterborough, UK) in 96-well plate format, compatible with an ABI 7000 real-time PCR machine, were used to assay gene expression changes (three comparisons for each array type). Samples were added to the reaction plates and signal amplification by PCR was carried out using a Sybr-Green '1 step qRT-PCR kit' (Invitrogen). Analysis was carried out using the Analysis Suite spreadsheet provided by Tebubio Superarrays. The absence of DNA contamination and efficiency of amplification was confirmed using the analysis software provided. Gene functions listed in Tables 1 to 3 were obtained from the SuperArray product specification sheets. Raw data for all of these array experiments can be found online [74].
###end p 79
###begin title 80
Quantitative Western blots
###end title 80
###begin p 81
###xml 705 707 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1711 1713 1709 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 898 902 <span type="species:ncbi:9925">Goat</span>
###xml 908 914 <span type="species:ncbi:9986">rabbit</span>
###xml 929 933 <span type="species:ncbi:9925">Goat</span>
###xml 939 944 <span type="species:ncbi:10090">mouse</span>
Cerebellar/cultured cell protein was separated by SDS-PAGE on 4% to 20% pre-cast NuPage 4% to 12% Bis Tris gradient gels (Invitrogen) and then transferred to PVDF membrane overnight. The membranes were then blocked using Odyssey blocking buffer (Li-COR Biosciences, Lincoln, Nebraska, USA) and incubated with primary antibodies as per manufacturers instructions (BRCA2, cAbl, CCL3 and E1 ubiquitin activating enzyme [Abcam, Cambridge, MA, USA]; anti-HDAC2 clone 3F3, anti-histone H2B and anti acetyl histone H3 [Lake Placid Biologicals, Lake Placid, NY, USA]; Pds1 Ab1 clone DCS280/Anti-Pttg1 [LabVision Corporation, Freemont, CA, USA]; and antiphosphohistone H2Ax [Upstate, Billerica, MA, USA]). Anti-Wlds antibodies were a kind gift from Dr Michael Coleman and were used as previously described [20,21]. Odyssey secondary antibodies were added in accordance with the manufacturer's instructions (Goat anti rabbit IRDye 680 and Goat anti mouse IRDye 800). Blots were imaged using an Odyssey Infrared Imaging System (Li-COR Biosciences). The scan resolution of the instrument ranges from 21 to 339 mum, and in this study blots were imaged at 169 mum. Quantification was performed on single channels with the analysis software provided. Bands were identified according to their relative molecular weight, as detailed in the manufacturer's antibody notes. Bands were delineated using Odyssey software and the arbitrary fluorescence intensity calculated by the software. For each membrane, scans were carried out at three different intensities in order to minimize possible user error in determining correct scan intensities or over-saturation of the membrane. The average of these three separate scans (giving an n of 1 per membrane) was used for further analysis.
###end p 81
###begin title 82
NT2 cell proliferation assays
###end title 82
###begin p 83
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
###xml 494 496 493 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 581 584 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 584 586 583 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 584 586 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s </italic></sup>
MTT assays were carried out in 96-well plates. One hundred micrograms of MTT was added to 6,000 cells per well of NT2 cells transfected with control (vector only) or Wlds constructs (200 ng [low dose], 600 ng [medium dose], and 1,200 ng [high dose]), and incubated for 3 hours. Media were then removed and formazan crystals dissolved in 50 mul dimethyl sulfoxide. The absorbance of the dimethyl sulfoxide was read at 545 nm to estimate cell number. For 3H-thymidine incorporation assays, 3 x 105 NT2 cells per well of a 24-well plate were transfected with control (vector only) or Wlds constructs, as detailed above, and proliferation assayed at 48 hours. Mitogenesis was estimated from the measurement of nuclear 3H-thymidine incorporation. Cells were incubated with 0.2 Ci 3H-thymidine (specific activity 70-95 Ci/mmol; Amersham Biosciences, Little Chalfont, UK) for the last 5 hours of culture incubation. Cells were then washed twice in ice-cold phosphate-buffered saline (PBS), followed by 1 ml cold 5% trichloroaceteic acid, and left on ice for 20 minutes. Then, 0.1 mol/l sodium hydroxide was added to the cells before transfer to 4 ml of scintillant. Radioactive counts were determined by scintillation counting. Experiments comprised four replicates each and were performed on at least two separate occasions.
###end p 83
###begin title 84
Immunocytochemistry
###end title 84
###begin p 85
###xml 368 370 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 425 426 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 271 277 <span type="species:ncbi:9913">bovine</span>
###xml 512 518 <span type="species:ncbi:9986">rabbit</span>
###xml 805 811 <span type="species:ncbi:9986">rabbit</span>
###xml 812 817 <span type="species:ncbi:10090">mouse</span>
###xml 902 908 <span type="species:ncbi:9986">rabbit</span>
###xml 909 914 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence staining was performed on either freshly cut (20 mum or 100 mum) cerebellar slices or HEK293 cells, fixed in 4% paraformaldehyde (Fisher Scientific, Loughborough, UK). Slices or cultured cells were incubated overnight in serum blocker consisting of 4% bovine serum albumin (Sigma) and 0.5% Triton X-100 (Sigma) in PBS. In cerebellar slices, anti-Wlds antibodies (1:500 dilution in serum blocking solution [8]) were applied overnight and, after washing with PBS saline, a TRITC-conjugated anti-rabbit secondary antibody (DAKO, Glostrup, Denmark) was applied overnight. Primary antibodies, including Ube1 (Abcam), VCP (Abcam), Sti1 (BD Transduction Laboratories, San Jose, CA, USA), and phosphohistone H2Ax (Upstate), were also used at concentrations specified by the manufacturers. Anti-rabbit/mouse FITC-conjugated secondary antibodies (DAKO) were used on cerebellar slices and anti-rabbit/mouse TRITC-conjugated secondary antibodies (DAKO) were used on HEK293 cells. Secondary antibody only controls were also carried out and confirmed the specificity of antibodies used (data not shown). Finally, cerebellar slices and cultured cells were then washed in PBS and incubated in TOPRO 3 (Molecular Probes, Carlsbad, CA, USA) for 10 minutes before mounting in Mowoil.
###end p 85
###begin p 86
Staining was visualised on a laser scanning confocal microscope (BioRad Radiance 2000; BioRad, Hemel Hempsted, UK) and Z-series were merged using Lasersharp (BioRad) software.
###end p 86
###begin title 87
Data analysis
###end title 87
###begin p 88
All non-SuperArray data were collected in Microsoft Excel and all statistical analyses and graphs were produced using GraphPad Prism. Quantification of cytoplasmic and nuclear Ube1/TOPRO3 fluorescence was undertaken on confocal micrographs captured using identical microscope settings between images and specimens. No image manipulation was undertaken before quantification using standard fluorescence intensity tools in Image J software. Images were prepared for presentation in Adobe Photoshop.
###end p 88
###begin title 89
Abbreviations
###end title 89
###begin p 90
###xml 459 462 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
eGFP, enhanced green fluorescent protein; MTT, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide; NAD, nicotinamide adenine dinucleotide; Nmnat1, nicotinamide mononucleotide adenylyltransferase 1; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; Pttg1, pituitary tumor transforming gene 1; STI1, stress-induced phosphoprotein 1; Ube1, ubiquitin-activating enzyme E1; Ube4b, ubiquitination factor E4B; VCP, valosin-containing protein; Wlds, slow Wallerian degeneration.
###end p 90
###begin title 91
Authors' contributions
###end title 91
###begin p 92
TMW and THG conceived, designed and coordinated the study, undertook the genomic, proteomic and immunocytochemical assays and drafted the manuscript. HNP, SRJ, and CJM carried out the cell proliferation assays. All authors read and approved the final manuscript.
###end p 92
###begin title 93
Acknowledgements
###end title 93
###begin p 94
The authors would like to thank Sara Meredith and Dr Emma Perkins for assistance with some of the immunocytochemical experiments, Derek Thomson for assistance with animal breeding, Dr N Cashman for providing NSC34 cells, and Dr Simon Parson and members of the Gillingwater and Parson laboratories for helpful discussion and comments on the manuscript. Flavopiridol was kindly provided by Sanofi-Aventis Pharmaceuticals Inc. through an agreement with the National Cancer Institute (Rockville, MD, USA). This work was supported by grants from the BBSRC (THG/TMW), Medical Research Scotland (THG), and the MRC (HNP/CJM).
###end p 94
###begin article-title 95
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Compartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse.
###end article-title 95
###begin article-title 96
Axonal destruction and neurodegeneration.
###end article-title 96
###begin article-title 97
Axon pathology in neurological disease: a neglected therapeutic target.
###end article-title 97
###begin article-title 98
Synaptic vulnerability in neurodegenerative disease.
###end article-title 98
###begin article-title 99
Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve.
###end article-title 99
###begin article-title 100
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Delayed Wallerian degeneration in the central nervous system of Ola mice: an ultrastructural study.
###end article-title 100
###begin article-title 101
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57Bl/Wlds).
###end article-title 101
###begin article-title 102
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy.
###end article-title 102
###begin article-title 103
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease.
###end article-title 103
###begin article-title 104
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease.
###end article-title 104
###begin article-title 105
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
The slow Wallerian degeneration gene, Wlds, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
###end article-title 105
###begin article-title 106
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion.
###end article-title 106
###begin article-title 107
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse.
###end article-title 107
###begin article-title 108
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
###end article-title 108
###begin article-title 109
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
###xml 2 5 <span type="species:ncbi:10116">rat</span>
A rat model of slow Wallerian degeneration (Wlds) with improved preservation of neuromuscular synapses.
###end article-title 109
###begin article-title 110
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons.
###end article-title 110
###begin article-title 111
Neurites can remain viable after the destruction of the neuronal soma by programmed cell death.
###end article-title 111
###begin article-title 112
The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
###end article-title 112
###begin article-title 113
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Degeneration of neuronal cell bodies following axonal injury in Wlds mice.
###end article-title 113
###begin article-title 114
The cellular distribution of the Wlds chimeric protein and its constituent proteins in the CNS.
###end article-title 114
###begin article-title 115
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s </sup>
###xml 73 77 <span type="species:ncbi:10090">Mice</span>
Neuroprotection after transient global cerebral ischaemia in Wlds Mutant Mice.
###end article-title 115
###begin article-title 116
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.
###end article-title 116
###begin article-title 117
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
###end article-title 117
###begin article-title 118
A local mechanism mediates NAD-dependent protection of axon degeneration.
###end article-title 118
###begin article-title 119
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy.
###end article-title 119
###begin article-title 120
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
NAD+ and axon degeneration revisited: Nmnat1 cannot substitute for WldS to delay Wallerian degeneration.
###end article-title 120
###begin article-title 121
Protection of vincristine-induced neuropathy by Wld(S) expression and the independence of the activity of Nmnat1.
###end article-title 121
###begin article-title 122
The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.
###end article-title 122
###begin article-title 123
The neuroprotective effects of the WldS gene are correlated with proteasome expression rather than apoptosis.
###end article-title 123
###begin article-title 124
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
###end article-title 124
###begin article-title 125
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wld</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s</italic>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>s</italic></sup>
Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.
###end article-title 125
###begin article-title 126
Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.
###end article-title 126
###begin article-title 127
Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.
###end article-title 127
###begin article-title 128
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 43 53 <span type="species:ncbi:7227">Drosophila</span>
The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously.
###end article-title 128
###begin article-title 129
Abnormal integrity of the nucleolus associated with cell cycle arrest owing to the temperature-sensitive ubiquitin-activating enzyme E1.
###end article-title 129
###begin article-title 130
The ubiquitin-activating enzyme E1 is phosphorylated and localized to the nucleus in a cell cycle-dependent manner.
###end article-title 130
###begin article-title 131
Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p.
###end article-title 131
###begin article-title 132
###xml 49 55 <span type="species:ncbi:9606">humans</span>
The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.
###end article-title 132
###begin article-title 133
Mammalian sirtuins: emerging roles in physiology, aging, and calorie restriction.
###end article-title 133
###begin article-title 134
Progressive loss of SIRT1 with cell cycle withdrawal.
###end article-title 134
###begin article-title 135
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
###end article-title 135
###begin article-title 136
###xml 19 24 <span type="species:ncbi:9606">human</span>
The cell cycle and human neurodegenerative disease.
###end article-title 136
###begin article-title 137
Oxidative stress, cell cycle, and neurodegeneration.
###end article-title 137
###begin article-title 138
###xml 57 67 57 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 57 67 <span type="species:ncbi:7227">Drosophila</span>
Connecting cell-cycle activation to neurodegeneration in Drosophila.
###end article-title 138
###begin article-title 139
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis.
###end article-title 139
###begin article-title 140
Mitotic mechanisms in Alzheimer's disease?
###end article-title 140
###begin article-title 141
###xml 76 79 <span type="species:ncbi:9606">man</span>
Neuronal expression of cell cycle-related proteins after brain ischaemia in man.
###end article-title 141
###begin article-title 142
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
###end article-title 142
###begin article-title 143
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat.
###end article-title 143
###begin article-title 144
The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes.
###end article-title 144
###begin article-title 145
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.
###end article-title 145
###begin article-title 146
Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
###end article-title 146
###begin article-title 147
Regulation of cell cycle progression and gene expression by H2A deubiquitination.
###end article-title 147
###begin article-title 148
The enhancement of histone H4 and H2A serine 1 phosphorylation during mitosis and S-phase is evolutionarily conserved.
###end article-title 148
###begin article-title 149
###xml 25 30 <span type="species:ncbi:9606">human</span>
PTTG and PBF repress the human sodium iodide symporter.
###end article-title 149
###begin article-title 150
Ufd2, a novel autoantigen in scleroderma, regulates sister chromatid separation.
###end article-title 150
###begin article-title 151
###xml 74 79 <span type="species:ncbi:9606">human</span>
Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells.
###end article-title 151
###begin article-title 152
Cell division in the CNS: protective response or lethal event in post-mitotic neurons?
###end article-title 152
###begin article-title 153
Molecular basis of programmed cell death involved in neurodegeneration.
###end article-title 153
###begin article-title 154
Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3.
###end article-title 154
###begin article-title 155
Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.
###end article-title 155
###begin article-title 156
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a.
###end article-title 156
###begin article-title 157
VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells.
###end article-title 157
###begin article-title 158
Caspase 3 activation is essential for neuroprotection in preconditioning.
###end article-title 158
###begin article-title 159
Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses.
###end article-title 159
###begin article-title 160
###xml 89 92 <span type="species:ncbi:10116">rat</span>
Transient glucose and amino acid deprivation induces delayed preconditioning in cultured rat cortical neurons.
###end article-title 160
###begin article-title 161
Molecular physiology of preconditioning-induced brain tolerance to ischemia.
###end article-title 161
###begin article-title 162
NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.
###end article-title 162
###begin article-title 163
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress.
###end article-title 163
###begin article-title 164
Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways.
###end article-title 164
###begin article-title 165
STI1 promotes glioma proliferation through MAPK and PI3K pathways.
###end article-title 165
###begin article-title 166
Hop/STI1 modulates retinal proliferation and cell death independent of PrPC.
###end article-title 166
###begin article-title 167
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.
###end article-title 167
###begin article-title 168
Raw array data
###end article-title 168

